Search

everythinglearnresearchcommunity

for

Search:↓

New drugs face challenges due to limited evidence, and safety updates are advised for some existing medications.

Sorafenib can cause delayed skin problems, so patients need careful monitoring.

The new gel combining minoxidil and tofacitinib effectively treats alopecia areata by promoting hair growth and reducing inflammation.

Flubendazole in a nanoemulsion can potentially treat lung cancer and cryptococcal meningitis effectively and safely.

The treatment with Shunyou and prednisone is effective and safe for lupus nephritis.

The patient's symptoms improved with treatment but recurred when the steroid dose was reduced, requiring ongoing therapy.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

Farudodstat may effectively treat alopecia areata by protecting hair follicles without harmful effects.

Methotrexate is best for lichen planopilaris, and retinoids are best for frontal fibrosing alopecia, but side effects are common.

The authors suggest that 5-α-reductase inhibitors, like dutasteride, are effective in treating frontal fibrosing alopecia and should be the first-line treatment, with other options for severe cases. They also recommend further research on Janus kinase inhibitors.

The new compound may be a safer alternative to finasteride for prostate protection.

Frontal Fibrosing Alopecia is a type of hair loss that mainly affects postmenopausal women, has unclear causes, and lacks evidence-based treatments.

The review suggests there's no agreed treatment for Frontal Fibrosing Alopecia, but hydroxychloroquine and 5a-reductase inhibitors are most effective. New treatments like platelet-rich plasma and LED light could help if standard treatments fail.

Current treatments for postmenopausal frontal fibrosing alopecia stop hair loss but don't regrow hair.

A woman with Fox-Fordyce disease had symptom relief using tretinoin cream.

Flibanserin may help improve sexual symptoms in various conditions beyond its approved use.

Polymeric micelle nanocarriers deliver adapalene more effectively to hair follicles than commercial products.

The new fluoroquinolone effectively fights certain bacteria.

Lifestyle changes are more effective than medication for reducing type 2 diabetes risk.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

A dog developed a skin condition called pemphigus foliaceus after taking NexGard, but got better with treatment.

Tofacitinib may help treat hair loss in children with alopecia areata.

A rare type of skin cancer with mucosal involvement was partially treated but eventually relapsed.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

Photodynamic therapy improved skin issues from sorafenib when other treatments failed.

D-OCT shows increased blood vessel growth in response to tissue damage in Frontal Fibrosing Alopecia and is useful for diagnosis and monitoring.

Frontal fibrosing alopecia is a challenging hair loss condition with no known cause or definitive treatment.

Afatinib often causes skin problems that need proactive management.